Replies to post #6936 on ANI Pharmaceuticals (ANIP)

[jeffqdhsr]

sandrinomazzulatore

Thanks for sharing , In all fairness to Mr Simes his part @ Unimed Pharm developing what later became Androgel and @ Bpax Libigel Maybe ?

Regardless he took part in taking Bpax to ANI , I spoke to him prior to ANI Acquiring he seems like a nice guy and knowing what we know now it was a good move! JMHO

[Just the facts maam]

Sandrinomazzulatore, In fairness to Simes, he doesn't approve the merger it was the BOD, led by Dr. Louis W. Sullivan as Chairman for the entire time Simes was at BPAX.

Simes had to tiptoe around a non-disclosure agreement and allow himself to be vilified by some as one of the worst CEO, knowing full well he was sitting on such a major discovery. Those of us who could look beyond his towing the company line and do our own research were rewarded if we chose to dollar cost averaging downward.

Without being able to announce the discovery, BPAX would have diluted much greater, than it did by merging ANIP, a profitable company. Any future dilution would not be to remain alive until the FDA 5 year follow up was completed and AbbVie made it's decision.

It is a shame he could not have confided with us. But that is the nature of confidentiality agreements.

In ANIP it is a profitable company with much promise. I believe the initial intent was to co-promote to maximize shareholder value. However AbbVie may have change its mind. This could be an exercise to quietly see what a fair price would be for ANIP.

Time will tell.

JMHO.

[Just the facts maam]

Sounds good Sandrino.